Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial
Top Cited Papers
Open Access
- 1 September 2017
- journal article
- clinical trial
- Published by Elsevier in Heart Rhythm
- Vol. 14 (9) , 1302-1308
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial FibrillationJACC, 2015
- Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial FibrillationJAMA, 2014
- TCT-176 Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in RiskJACC, 2014
- Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin TherapyJACC, 2014
- Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: A prospective single-center experienceHeart Rhythm, 2013
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort studyEuropean Heart Journal, 2012
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial FibrillationJACC, 2011
- Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research ConsortiumEuropean Heart Journal, 2010
- Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillationThe Annals of Thoracic Surgery, 1996